Paper42939751PubMed
Bile Acids and Their Receptors in Respiratory Diseases: Mechanistic and Therapeutic Perspectives.
Wan J and 9 others. Biomolecules, 2026.
Cite this record
ConductScience Library. Bile Acids and Their Receptors in Respiratory Diseases: Mechanistic and Therapeutic Perspectives. Papers, record 42939751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42939751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bile Acids and Their Receptors in Respiratory Diseases: Mechanistic and Therapeutic Perspectives.
- Journal
- Biomolecules
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bile Acids and Salts | Major topic |
| Respiratory Tract Diseases | Major topic |
| Humans | |
| Animals | |
| Signal Transduction | |
| Asthma |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2023AB045, 2024AB071 | the projects of Corps Science and Technology Plan Project | PubMed | ||
| 82560831 | National Natural Science Foundation of China | PubMed |
Source PubMed
References135
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30150987 | Bile Acids Activated Receptors Regulate Innate Immunity. | Front Immunol | 2018 | https://conductscience.org/library/papers/30150987 | PubMed |
| 2 | 35955473 | Interactive Relationships between Intestinal Flora and Bile Acids. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35955473 | PubMed |
| 3 | 39317054 | Taurochenodeoxycholic acid ameliorates the Staphylococcus aureus infection-induced acute lung injury through toll-like receptor 2 in mice. | Int Immunopharmacol | 2024 | https://conductscience.org/library/papers/39317054 | PubMed |
| 4 | 37188530 | Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid. | J Pharmacol Exp Ther | 2024 | https://conductscience.org/library/papers/37188530 | PubMed |
| 5 | 34022896 | RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma. | Respir Res | 2021 | https://conductscience.org/library/papers/34022896 | PubMed |
| 6 | 31344409 | Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells. | Steroids | 2019 | https://conductscience.org/library/papers/31344409 | PubMed |
| 7 | 40985894 | FXR shapes an immunosuppressive microenvironment in PD-L1lo/- non-small cell lung cancer by upregulating HVEM. | JCI Insight | 2025 | https://conductscience.org/library/papers/40985894 | PubMed |
| 8 | 36076570 | Iguratimod ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the EMT process and NLRP3 inflammasome activation. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/36076570 | PubMed |
| 9 | 33252713 | Targeting the alternative bile acid synthetic pathway for metabolic diseases. | Protein Cell | 2021 | https://conductscience.org/library/papers/33252713 | PubMed |
| 10 | 37515688 | Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis. | Sci China Life Sci | 2024 | https://conductscience.org/library/papers/37515688 | PubMed |
| 11 | 40378940 | Novel microbially transformed bile acids: Biosynthesis, structure, and function. | Pharmacol Res | 2025 | https://conductscience.org/library/papers/40378940 | PubMed |
| 12 | 36470304 | FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. | Nature | 2023 | https://conductscience.org/library/papers/36470304 | PubMed |
| 13 | 12524422 | A G protein-coupled receptor responsive to bile acids. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12524422 | PubMed |
| 14 | 36016948 | Advances in the use of exosomes for the treatment of ALI/ARDS. | Front Immunol | 2022 | https://conductscience.org/library/papers/36016948 | PubMed |
| 15 | 38280762 | Viral Pneumonias. | Infect Dis Clin North Am | 2024 | https://conductscience.org/library/papers/38280762 | PubMed |
| 16 | 35797724 | Bile acid-induced lung injury: update of reverse translational biology. | Am J Physiol Lung Cell Mol Physiol | 2022 | https://conductscience.org/library/papers/35797724 | PubMed |
| 17 | 37948864 | Ursodeoxycholic acid alleviates sepsis-induced lung injury by blocking PANoptosis via STING pathway. | Int Immunopharmacol | 2023 | https://conductscience.org/library/papers/37948864 | PubMed |
| 18 | 36323778 | Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation. | Nature | 2022 | https://conductscience.org/library/papers/36323778 | PubMed |
| 19 | 26067554 | Chenodeoxycholic acid attenuates ovalbumin-induced airway inflammation in murine model of asthma by inhibiting the T(H)2 cytokines. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/26067554 | PubMed |
| 20 | 28256288 | Beneficial effects of ursodeoxycholic acid via inhibition of airway remodelling, apoptosis of airway epithelial cells, and Th2 immune response in murine model of chronic asthma. | Allergol Immunopathol (Madr) | 2017 | https://conductscience.org/library/papers/28256288 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42939751
GET https://conductscience.org/api/papers/v1/42939751/references?page=2